Browsing Tag
SAPIR
2 posts
GSK dodges tariffs with a massive pricing pivot—but what’s the catch?
GlaxoSmithKline cuts drug prices in the U.S. and secures tariff relief under a new federal deal. Find out what this means for pharma's future pricing playbook.
Inside the new plan to end U.S. dependence on foreign drug ingredients — will it work this time?
Trump orders immediate filling of U.S. strategic API reserve with domestic production focus. See how this plan aims to secure critical medicine supply.